DigiDiab Evaluation Domiciliary Nursing Care
Launched by MEDICAL UNIVERSITY OF GRAZ · Sep 24, 2024
Trial Information
Current as of June 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The DigiDiab Evaluation Domiciliary Nursing Care trial is studying a software system called GlucoTab, which aims to help healthcare professionals provide better care for patients with type 2 diabetes who need insulin treatment. This system includes a therapy plan to help manage insulin therapy effectively for those patients. The trial will focus on how well this software can support individuals receiving care at home.
To be eligible for this trial, participants need to be at least 18 years old, diagnosed with type 2 diabetes, and currently receiving nursing care at home. Unfortunately, those with type 1 diabetes, certain severe conditions, or other specific health issues cannot participate. If you join the study, you'll receive support from healthcare professionals using the GlucoTab system to help manage your diabetes. It's important to know that the trial is not yet recruiting participants, so keep an eye out for updates if you're interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent obtained after being advised of the nature of the study
- • Male or female aged ≥ 18 years
- • Type 2 diabetes (treated with insulin therapy)
- • Receiving domiciliary nursing care
- Exclusion Criteria:
- • type 1 diabetes mellitus
- • intravenous insulin therapy
- • hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy
- • continuous subcutaneous insulin infusion
- • gestational diabetes or pregnancy
- • known or suspected allergy to insulin
- • total parenteral nutrition
- • any mental condition rendering the patient incapable of giving his/her consent
- • any disease or condition which according to the investigator would interfere with the trial or the safety of the patient
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported